Successful Treatment of a Pacemaker Infection with Intraperitoneal Daptomycin.

We investigated the pharmacokinetics of intraperitoneal administration of daptomcyin in a peritoneal dialysis (PD) patient treated for a pacemaker infection with Staphylococcus epidermidis. After initial start of intravenous daptomycin at 9 mg/kg body weight every 48 hours, the therapy was switched to intraperitoneal administration of 5.3 mg/kg body weight in 1 L icodextrin 7.

Severe hyperkalemia following colon diversion surgery in a patient undergoing chronic hemodialysis: a case report.

Introduction: Potassium (K+) homeostasis in healthy subjects is maintained mainly by urinary excretion of K+. In patients with end-stage renal disease, the intestinal tract might assume an accessory K+ excretory role in the face of declining renal excretory function. Here, we report the case of a patient with end-stage renal disease who developed severe hyperkalemia following colon diversion surgery.

Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study.

Objective: Control of airway inflammation is the cornerstone of asthma management. The aim of the present pilot study was to assess the effects of a leukotriene receptor antagonist (LTRA) added to a basic treatment of inhaled corticosteroids (ICS) and long-acting beta-agonist (LABA) on airway hyperresponsiveness, inflammation, and quality of life in well-controlled patients with asthma.

Research Design And Methods: Seventeen patients (age 18-65, 11 women) with well-controlled asthma presenting airway hyperresponsiveness to mannitol and methacholine challenge were given add-on montelukast on a stable ICS + LABA for 4 weeks.

[Fever of unknown origin (FUO)].

Despite the fact that the appearance of fever is related to certain diseases, in general medical practice there are still no good and reliable parameters to specify the underlying cause of fever. There is still a lot of insecurity regarding urgency, necessity, duration and form of treatment for many diseases because of the lack of reliable markers.Biomarkers like Procalcitonin, IL-6 and IL-8 show first solutions but there are still many unanswered questions.